Abiopharma

Clinical trial NCT06993142 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-07-01 → 2025-09-01

Clinical trial NCT07712874: start date: 2026-08-31 → 2026-09-01.

Clinical trial NCT05150691: primary completion date: 2026-04-01 → 2027-08-01.

Clinical trial NCT07298863 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-04-30 → 2026-09-01 3. primary completion date: 2026-04-01 → 2026-09-01 4. enrollment: 74 → 104 participants 5. collaborators added: PeakGenics Innovation Inc.

Clinical trial NCT07709000: start date: 2026-08-21 → 2026-09-11.

Clinical trial NCT06525389 updates: 1. start date: 2026-07-01 → 2026-09-01 2. completion date: 2031-07-01 → 2031-09-01 3. primary completion date: 2030-07-01 → 2030-09-01

Clinical trial NCT06233461: primary completion date: 2026-09-18 → 2027-02-17.

Clinical trial NCT07071961: status: SUSPENDED → RECRUITING.

Clinical trial NCT04962061 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2026-03-03 3. primary completion date: 2025-12-31 → 2026-02-06 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07652359: start date: 2026-07-14 → 2026-08-26.

Clinical trial NCT05952258: enrollment: 158 → 220 participants.

Clinical trial NCT06398561 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2027-09-30 → 2026-04-28 3. primary completion date: 2025-05-20 → 2026-04-28 4. enrollment: 70 → 81 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06100822 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-09-30 → 2026-08-24 3. primary completion date: 2026-08-31 → 2026-08-24 4. enrollment: 40 → 21 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07505030 updates: 1. status: NOT_YET_RECRUITING → ENROLLING_BY_INVITATION 2. start date: 2026-05-25 → 2026-05-28

Clinical trial NCT07295431 updates: 1. status: NOT_YET_RECRUITING → COMPLETED 2. start date: 2026-01-15 → 2026-03-04 3. completion date: 2026-07-31 → 2026-07-24 4. primary completion date: 2026-05-31 → 2026-07-24 5. enrollment: 114 → 116 participants 6. enrollment type: ESTIMATED → ACTUAL